**Weekly News Sentiment: Neutral**

The current week's news sentiment is neutral, with two news articles having opposite tones.

**Notable Events:**

1. **Sun Pharma appoints Tejash Chheda as General Manager - Head of Media**: This news is likely to have a positive impact on the stock, similar to previous appointments of independent directors and whole-time directors, which had a positive impact on the stock price.
2. **Pharma stocks: Nomura gives 'Buy' to Lupin remains 'Neutral' on others**: This news is neutral for Sun Pharma, as the brokerage firm Nomura has given a 'Buy' rating to Lupin, but remains neutral on other pharma stocks, including Sun Pharma.

**Historical Similar News and Price Impact:**

The historical data suggests that appointments of key personnel have had a positive impact on Sun Pharma's stock price, with an average impact of +2.55%. On the other hand, news related to brokerages' ratings has had a mixed impact, with an average impact of -0.58%.

Overall, the news tone is neutral, with one positive news article and one neutral news article. The impact of these news articles on the stock price is likely to be minimal, unless there are other market or company-specific factors that influence the stock's performance.